219 related articles for article (PubMed ID: 26830551)
41. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
[TBL] [Abstract][Full Text] [Related]
42. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
[TBL] [Abstract][Full Text] [Related]
43. Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease.
De Blasiis P; Fullin A; Sansone M; Del Viscovo L; Napolitano F; Terracciano C; Lus G; Melone MAB; Sampaolo S
J Neuromuscul Dis; 2021; 8(6):979-988. PubMed ID: 34120910
[TBL] [Abstract][Full Text] [Related]
44. Successful combined liver/kidney transplantation from a donor with Pompe disease.
Halldorson J; Kazi Z; Mekeel K; Kuo A; Hassanein T; Loomba R; Austin S; Valasek MA; Kishnani P; Hemming AW
Mol Genet Metab; 2015 Aug; 115(4):141-4. PubMed ID: 26031770
[TBL] [Abstract][Full Text] [Related]
45. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
46. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
Meznaric M; Fumic K; Leonardis L
J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
[TBL] [Abstract][Full Text] [Related]
47. Pain in adult patients with Pompe disease: a cross-sectional survey.
Güngör D; Schober AK; Kruijshaar ME; Plug I; Karabul N; Deschauer M; van Doorn PA; van der Ploeg AT; Schoser B; Hanisch F
Mol Genet Metab; 2013 Aug; 109(4):371-6. PubMed ID: 23849261
[TBL] [Abstract][Full Text] [Related]
48. The genotype-phenotype correlation in Pompe disease.
Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
[TBL] [Abstract][Full Text] [Related]
49. Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease.
Refai D; Lev R; Cross DT; Shimony JS; Leonard JR
Surg Neurol; 2008 Nov; 70(5):518-20. PubMed ID: 18207222
[TBL] [Abstract][Full Text] [Related]
50. Investigation on acute effects of enzyme replacement therapy and influence of clinical severity on physiological variables related to exercise tolerance in patients with late onset Pompe disease.
Sechi A; Salvadego D; Da Ponte A; Bertin N; Dardis A; Cattarossi S; Devigili G; Reccardini F; Bembi B; Grassi B
Neuromuscul Disord; 2017 Jun; 27(6):542-549. PubMed ID: 28433478
[TBL] [Abstract][Full Text] [Related]
51. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA.
Xu F; Ding E; Migone F; Serra D; Schneider A; Chen YT; Amalfitano A
J Gene Med; 2005 Feb; 7(2):171-8. PubMed ID: 15515143
[TBL] [Abstract][Full Text] [Related]
52. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.
Gaeta M; Musumeci O; Mondello S; Ruggeri P; Montagnese F; Cucinotta M; Vinci S; Milardi D; Toscano A
Neuromuscul Disord; 2015 Nov; 25(11):852-8. PubMed ID: 26410244
[TBL] [Abstract][Full Text] [Related]
53. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
[TBL] [Abstract][Full Text] [Related]
54. Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts.
Quenardelle V; Bataillard M; Bazin D; Lannes B; Wolff V; Echaniz-Laguna A
J Neurol; 2015 Feb; 262(2):473-5. PubMed ID: 25451853
[No Abstract] [Full Text] [Related]
55. Screening for late-onset Pompe disease in western Denmark.
Hansen JS; Pedersen EG; Gaist D; Bach FW; Vilholm OJ; Sandal B; Weitemeyer L; Nielsen K; Schlesinger FE; Preisler N; Vissing J; Andersen H
Acta Neurol Scand; 2018 Jan; 137(1):85-90. PubMed ID: 28832912
[TBL] [Abstract][Full Text] [Related]
56. LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population.
Musumeci O; la Marca G; Spada M; Mondello S; Danesino C; Comi GP; Pegoraro E; Antonini G; Marrosu G; Liguori R; Morandi L; Moggio M; Massa R; Ravaglia S; Di Muzio A; Filosto M; Tonin P; Di Iorio G; Servidei S; Siciliano G; Angelini C; Mongini T; Toscano A;
J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):5-11. PubMed ID: 25783438
[TBL] [Abstract][Full Text] [Related]
57. Pompe disease in Austria: clinical, genetic and epidemiological aspects.
Löscher WN; Huemer M; Stulnig TM; Simschitz P; Iglseder S; Eggers C; Moser H; Möslinger D; Freilinger M; Lagler F; Grinzinger S; Reichhardt M; Bittner RE; Schmidt WM; Lex U; Brunner-Krainz M; Quasthoff S; Wanschitz JV
J Neurol; 2018 Jan; 265(1):159-164. PubMed ID: 29181627
[TBL] [Abstract][Full Text] [Related]
58. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
59. Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
Starbuck C; Reay J; Silk E; Roberts M; Hendriksz C; Jones R
Hum Mov Sci; 2021 Jun; 77():102777. PubMed ID: 33730657
[TBL] [Abstract][Full Text] [Related]
60. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.
Sacconi S; Bocquet JD; Chanalet S; Tanant V; Salviati L; Desnuelle C
J Neurol; 2010 Oct; 257(10):1730-3. PubMed ID: 20559845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
